Literature DB >> 8971744

Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.

K Brockmann1, P J Pouwels, H J Christen, J Frahm, F Hanefeld.   

Abstract

Cerebral metabolic abnormalities in five children with infantile (1), late infantile (1), and juvenile (3) neuronal ceroid lipofuscinosis (NCL) were noninvasively assessed by localized proton magnetic resonance spectroscopy (MRS). Infantile NCL was characterized by a complete loss of N-acetylaspartate (NAA, neuronal marker), a marked reduction of creatines (Cr) and choline-containing compounds (Cho), and an elevation of myo-inositol (Ins, glial marker) and lactate (Lac) in both gray and white matter. Reduced NAA and elevated Lac were also detected in gray and white matter of late infantile NCL, but in this case not only Ins but also Cr and Cho were increased in white matter. In contrast to the infantile forms, juvenile NCL exhibited normal metabolic profiles. In one patient disease progression was indicated by reduced NAA and Cr in gray matter in a follow-up study after four years. The present findings in NCL are consistent with irreversible and generalized neuroaxonal loss as well as alterations of white matter glia similar to those found in leukodystrophies. The severity of metabolic disturbances correlates with clinical symptoms and decreasing age of onset.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971744     DOI: 10.1055/s-2007-973772

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  7 in total

1.  Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes.

Authors:  M H Baslow; R F Suckow; V Sapirstein; B L Hungund
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

2.  Barbiturate anesthesia and brain proton spectroscopy.

Authors:  N M Lundbom; T Manner; M Komu; O Peltola; K A Leino; O A Kirvelä
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

3.  Molecular neurodevelopment: an in vivo 31P-1H MRSI study.

Authors:  Gerald Goldstein; Kanagasabai Panchalingam; Richard J McClure; Jeffrey A Stanley; Vince D Calhoun; Godfrey D Pearlson; Jay W Pettegrew
Journal:  J Int Neuropsychol Soc       Date:  2009-08-13       Impact factor: 2.892

4.  Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation.

Authors:  Kakulavarapu V Rama Rao; Tammy Kielian
Journal:  Clin Exp Neuroimmunol       Date:  2015-08-03

5.  Astrocytes in juvenile neuronal ceroid lipofuscinosis (CLN3) display metabolic and calcium signaling abnormalities.

Authors:  Megan E Bosch; Tammy Kielian
Journal:  J Neurochem       Date:  2018-08-16       Impact factor: 5.372

6.  Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).

Authors:  Amy Aldrich; Megan E Bosch; Rachel Fallet; Jessica Odvody; Maria Burkovetskaya; Kakulavarapu V Rama Rao; Jonathan D Cooper; Arlene V Drack; Tammy Kielian
Journal:  Ann Neurol       Date:  2016-11-23       Impact factor: 10.422

7.  Evidence for aberrant astrocyte hemichannel activity in Juvenile Neuronal Ceroid Lipofuscinosis (JNCL).

Authors:  Maria Burkovetskaya; Nikolay Karpuk; Juan Xiong; Megan Bosch; Michael D Boska; Hideyuki Takeuchi; Akio Suzumura; Tammy Kielian
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.